top of page
Report Summary
Market Overview

Global Point-of-Care Diagnostics Market Size, Share, Growth, Trends, and Forecast (2024 - 2031)

Global Point-of-Care Diagnostics Market Scope: Historical Data (2021 – 2022), Base Year (2023), Forecast Period (2024 – 2031)


Market Segmentation: By Product (Glucose Monitoring Kit, Cardio-metabolic Monitoring Kit, Pregnancy and Fertility Testing Kit, Infectious Disease Testing Kit, Cholesterol Test Strip, Hematology Testing Kit, and Other Products), End User (Hospital and Critical Care Setting, Ambulatory Care Setting, Research Laboratory, and Other End Users), and Region (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa)


Market Overview


The Global Point-of-Care Diagnostics Market was valued at USD 45,838.0 million in 2023 and is expected to reach USD 77,588.2 million by 2031 while growing at a CAGR of 6.8% during the forecast period (2024-2031).

*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report


Market Dynamics


This section of the report will analyze various driving and restraining factors that are expected to have a significant impact on the global point-of-care diagnostics market growth. Point-of-care diagnostics (POC diagnostics) are medical tests or assays conducted near the patient, often at the bedside, clinic, or in the field, rather than in a centralized laboratory setting, aiming to deliver swift results for immediate clinical decision-making and patient management.


The growing prevalence of chronic diseases and the rise of personalized medicine propel the point of care diagnostics market, yet challenges such as quality assurance, standardization, and regulatory hurdles could hinder its growth.


Furthermore, the global point-of-care diagnostics industry will be analyzed through various tools including PESTLE analysis, and Porter’s analysis.


Segmentation – By Product Analysis


The Global Point-of-Care Diagnostics Market is segmented among Glucose Monitoring Kit, Cardio-metabolic Monitoring Kit, Pregnancy and Fertility Testing Kit, Infectious Disease Testing Kit, Cholesterol Test Strip, Hematology Testing Kit, and Other Products, based on Product. In 2023, Infectious Disease Testing Kit accounted for the majority of the market share*.

*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report


Segmentation – By End User Analysis


The Global Point-of-Care Diagnostics Market is segmented among Hospital and Critical Care Setting, Ambulatory Care Setting, Research Laboratory, and Other End Users, based on End User. In 2023, Hospital and Critical Care Setting accounted for the majority of the market share*.

*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report


Global Point-of-Care Diagnostics Market: Regional Analysis


Based on region, the market is divided into six regions including North America, Europe, Asia Pacific, Latin America, Middle East, and Africa. In 2023, North America dominated the market with the highest market share, while Asia Pacific is expected to grow with the highest CAGR during the forecast period (2024 – 2031).

*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report


Competitive Landscape


Some of the key players operating in the market are Abbott Laboratories, Siemens Healthineers AG, Danaher Corporation (Beckman Coulter Inc.), Becton, Dickinson and Company, Instrumentation Laboratory, Johnson and Johnson Inc., Nova Biomedical Corporation, Qiagen Inc., F. Hoffmann-La Roche Ltd., and Biomeriux SA


Table of Contents:


1. Research Methodology and Market Scope

  • Research Methodology

  • Market Scope

2. Executive Summary

3. Global Point-of-Care Diagnostics Market Dynamics

  • Drivers

  • Restraints

  • Opportunity

4. Global Point-of-Care Diagnostics Industry Analysis

  • PEST Analysis

  • Porter's Five Force Analysis

  • Recent Deals Analysis

5. Global Point-of-Care Diagnostics Market Segmentation, By Product 

  • Global Point-of-Care Diagnostics Market Share Analysis, By Product 

  • Global Point-of-Care Diagnostics Market Growth Analysis, By Product 

  • Global Point-of-Care Diagnostics Market Trends, By Product 

o Glucose Monitoring Kit

o Cardio-metabolic Monitoring Kit

o Pregnancy and Fertility Testing Kit

o Infectious Disease Testing Kit

o Cholesterol Test Strip

o Hematology Testing Kit

o Other Products

6. Global Point-of-Care Diagnostics Market Segmentation, By End User

  • Global Point-of-Care Diagnostics Market Share Analysis, By End User

  • Global Point-of-Care Diagnostics Market Growth Analysis, By End User

  • Global Point-of-Care Diagnostics Market Trends, By End User

o Hospital and Critical Care Setting

o Ambulatory Care Setting

o Research Laboratory

o Other End Users

7. Global Point-of-Care Diagnostics Market Segmentation, By Region

  • Global Point-of-Care Diagnostics Market Share Analysis, By Region

  • Global Point-of-Care Diagnostics Market Growth Analysis, By Region

  • Global Point-of-Care Diagnostics Market Trends, By Region

o North America

o Europe

o Asia Pacific

o Latin America

o Middle East

o Africa

8. Competitive Landscape

  • Abbott Laboratories*

o Company Overview

o Financial Performance

o Key Development/Strategies

o SWOT Analysis

  • Siemens Healthineers AG

  • Danaher Corporation (Beckman Coulter Inc.)

  • Becton, Dickinson and Company

  • Instrumentation Laboratory

  • Johnson and Johnson Inc.

  • Nova Biomedical Corporation

  • Qiagen Inc.

  • F. Hoffmann-La Roche Ltd.

  • Biomeriux SA

*Similar analysis will be provided for each company listed above.

REPORT.png
Pricing Plan
Segmentation
Regional Analysis
Table of Contents
bottom of page